Pharma

Your Article Summary

See Latest Articles

FDA Approves New 3000 IU Vial Size for Kogenate FS, antihemophilic factor (recombinant)
Bayer HealthCare Pharmaceuticals, 08/10/09

Bayer HealthCare Pharmaceuticals announced that the U.S. Food and Drug Administration has approved a 3000 IU vial size of Kogenate FS, antihemophilic factor. The new vial size offers greater convenience for patients with hemophilia A who require a higher dose.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

 See all of Drug/Product Approvals